Acutus Medical Appoints Duane Wilder as Chief Commercial Officer
Wilder brings deep expertise in Image Guided Therapy to help accelerate commercialization and market expansion effortsCARLSBAD, Calif., March 02, 2021...
Wilder brings deep expertise in Image Guided Therapy to help accelerate commercialization and market expansion effortsCARLSBAD, Calif., March 02, 2021...
--Placebo-controlled study to evaluate potential of NGM120, a novel inhibitor of GDF15/GFRAL pathway, to treat cancer and cancer-related cachexia-- --Cachexia, a...
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced...
EMERYVILLE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing next generation...
REHOVOT, Israel and WILMINGTON, Del., March 02, 2021 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company...
WARMINSTER, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage biopharmaceutical company primarily focused on...
Proceeds will advance two lead xenotransplantation programs in kidney failure and type 1 diabetes into first-in-human studiesCAMBRIDGE, Mass., March 02,...
IRVINE, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a clinical stage biopharmaceutical company focused...
SAN DIEGO, March 02, 2021 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential...
TORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic...
Proactive MD remains the only company in the primary care category to receive such validation for cost savingsGREENVILLE, March 02,...
BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company...
Posts Revenue Growth of 32% And Adjusted EBITDA Growth of 53% Recurring Revenue Grows to 75% of Total Revenue CINCINNATI,...
MELBOURNE, Australia, March 02, 2021 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: “CYP”, “Cynata”, or the “Company”), a clinical-stage biotechnology...
NEEDHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial-stage biopharmaceutical company, today announced that management...
Loughborough, England, March 02, 2021 (GLOBE NEWSWIRE) -- Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical technology...
Successfully demonstrates the Nanox.ARC in range of 2D and 3D imaging applications at the 2020 Radiology Society of North America...
Results indicate that GENFLEX meets new FDA guidance calling for COVID-19 test developers to assess the impact of viral mutations...
Company names new Chief Medical Officer, Chief Scientific Officer, and General Counsel and Chief Legal OfficerPALO ALTO, Calif., March 02,...
Registry will continue to advance the understanding of the clinical outcomes and management of recurrent pericarditis in partnership with the...